NAOV
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
31
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. The firm focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure.
emptyResult
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Tyler, Texas and currently employs 15 full-time employees. The company went IPO on 2015-04-24. The firm focuses on two distinct technology platforms: Acoustic-based therapeutic technologies, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology. These devices are intended for use in home or care settings and are designed to treat pain, reduce bacterial colonization, and disrupt biofilms. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters. The ENvue Navigation Platform, which is a minimally invasive electromagnetic navigation system intended to assist clinicians in placing feeding tubes into the gastrointestinal tract. ENvue provides real-time bedside visualization of tube movement and supports informed decision-making during the placement procedure.
Recently from Cashu
NanoVibronix Innovates Ultrasonic Technology for Pain Relief and Wound Healing in Healthcare
NanoVibronix Advances Ultrasonic Technology for Medical Applications NanoVibronix, a pioneer in the development of portable ultrasound technology, is making significant strides in the medical device i…
NanoVibronix (NAOV) Secures Patent, Enhancing Innovation in Medical Technology
NanoVibronix Secures Key Patent, Bolstering Innovation in Medical Technology NanoVibronix Inc. (NAOV) recently announces a significant milestone with the granting of a new U.S. patent to its subsidiar…
NanoVibronix (NAOV) Secures New Patent, Enhancing Position in Medical Technology Market
NanoVibronix Announces New Patent, Strengthening Market Position in Medical Technology NanoVibronix Inc. (NAOV) takes a significant step forward in the medical technology landscape with the recent ann…
NanoVibronix Acquires ENvue Medical to Enhance Enteral Feeding Solutions and Patient Care
NanoVibronix Expands Its Horizons with ENvue Medical Acquisition NanoVibronix, Inc., a prominent player in the medical technology sector, has successfully completed its acquisition of ENvue Medical Ho…